Norway (NO)

Selecting pharmacies for COVID-19 testing to ensure access (2021) Risanger S, Singh B, Morton DP, Meyers LA Journal article Scientific outcome of the IPBES-IPCC co-sponsored workshop on biodiversity and climate change (2021) Poertner HO, J. Scholes R, Agard J, Archer E, Arneth A, Bai X, Barnes DKA, et al. Other publication type, Report Correction to: Frequency of fatigue and its changes in the first 6 months after traumatic brain injury: results from the CENTER-TBI study (Journal of Neurology, (2021), 268, 1, (61-73), 10.1007/s00415-020-10022-2) (2021) Andelic N, Roe C, Bullet CB, Bullet MZ, Lovstad M, Loke D, Borgen IM, et al. Journal article, Erratum Investigating the prospect of leveraging blockchain and machine learning to secure vehicular networks: A survey (2021) Dibaei Asl M, Zheng X, Xu X, Xia Y, Jolfaei A, Kashif Bashir A, Tariq U, et al. Journal article The Gut Microbiome in Hypertension: Recent Advances and Future Perspectives (2021) Avery EG, Bartolomaeus H, Maifeld A, Marko L, Wiig H, Wilck N, Rosshart SP, et al. Journal article Corrigendum to: More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis. (2021) Parma V, Ohla K, Veldhuizen MG, Niv MY, Kelly CE, Bakke AJ, Cooper KW, et al. Journal article, Erratum Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. (2021) Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airo P, Ananieva LP, Czirjak L, et al. Journal article The DUNE framework: Basic concepts and recent developments (2021) Bastian P, Blatt M, Dedner A, Dreier NA, Engwer C, Fritze R, Gräser C, et al. Journal article Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice (2021) Artunc F, Bohnert BN, Schneider JC, Staudner T, Sure F, Ilyaskin A, Worn M, et al. Journal article PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution